Born 1957. Chairman of the Board of Directors since 2020.

Independent in relation to the Company and its management but independent in relation to major shareholders..

Education and experience: M.Sc. Chemical Engineering, Chalmers University of Technology, Ph.D. Department of Pure and Applied Biochemistry, Lund Institute of Technology, University of Lund. Lars has over 30 years’ experience from companies within life science, including over 25 years in leading positions. A big part of his career has involved research and development at for example AstraZeneca but Lars also has a vast experience in running and developing companies in life science.

Current assignments: CEO of Pharmiva AB, chairman and co-founder of IAmPatient AB, chariman of the board at Asgar Therapeutics and board member of CanImGuide, RhoVac AB (publ), Cell Invent AB, Immodulate Pharma and co-founder of several companies.

Previous assignments (last five years): Chairman of the Board of Directors at Lund Life Science Incubator.

Lars Hedbys holds 1,285 B-shares via company.